Zhejiang CONBA Pharmaceutical Co.,Ltd. (SHA:600572)
4.390
-0.060 (-1.35%)
Apr 30, 2025, 3:00 PM CST
SHA:600572 Revenue
In the year 2024, Zhejiang CONBA Pharmaceutical had annual revenue of 6.52B CNY, down -3.23%. Zhejiang CONBA Pharmaceutical had revenue of 1.60B in the quarter ending December 31, 2024, with 3.46% growth.
Revenue
6.52B
Revenue Growth
-3.23%
P/S Ratio
1.74
Revenue / Employee
758.02K
Employees
8,411
Market Cap
11.07B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 6.52B | -217.63M | -3.23% |
Dec 31, 2023 | 6.73B | 732.35M | 12.20% |
Dec 31, 2022 | 6.00B | -567.74M | -8.64% |
Dec 31, 2021 | 6.57B | 659.17M | 11.16% |
Dec 31, 2020 | 5.91B | -859.28M | -12.70% |
Dec 31, 2019 | Pro | Pro | Pro |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Jiangsu Hengrui Medicine | 29.19B |
Shenzhen Mindray Bio-Medical Electronics | 35.59B |
WuXi AppTec | 39.59B |
Zhangzhou Pientzehuang Pharmaceutical., | 10.76B |
Aier Eye Hospital Group | 21.81B |
Sichuan Biokin Pharmaceutical | 5.82B |
Shanghai United Imaging Healthcare | 10.43B |
Yunnan Baiyao Group Co.,Ltd | 40.10B |